Ajinomoto Cambrooke Email Formats
Pharmaceutical Manufacturing • 
Ayer, Massachusetts, United States • 51-100 Employees
Ajinomoto Cambrooke Email Formats
Ajinomoto Cambrooke uses 5 email formats. The most common is {first initial}{last name} (e.g., jdoe@cambrooke.com), used 56.4% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}{last name} | jdoe@cambrooke.com | 57.7% |
{first name}{last name} | johndoe@cambrooke.com | 39.7% |
{first initial} | j@cambrooke.com | 1.3% |
{last name}{last name} | doedoe@cambrooke.com | 1.3% |
Key Contacts at Ajinomoto Cambrooke
Natasha Raimondo
Sr. Director North America Sales, Market Access And Commercial Contract Operations
Kris Young
Director Corporate Strategy And Digital Transformation
John Abraham
Associate Director - Safety, Environmental, And Quality
Manoj Nair
Director Of Product Development
Valerie Barbieri
Human Resources Director
Susan Gingrich
Director Medical Nutrition
Company overview
| Headquarters | 4 Copeland Drive, Ayer, MA 01432, US |
| Phone number | +35722054064 |
| Website | |
| NAICS | 3254 |
| SIC | 202 |
| Keywords | Medical Foods, Cystic Fibrosis, GI, Protein Supplement, Nutritional Theraphy, Low Protein Foods, Glycomacropeptide, Glytactin Containing Gmp, Inborn Errors Of Metabolism, Ketogenic Therapies, Medical Formula, Metabolic Formula, Protein Allergy, Intractable Epilesy |
| Founded | 2000 |
| Employees | 51-100 |
| Socials |
About Ajinomoto Cambrooke
Ajinomoto Cambrooke, Inc. formerly Cambrooke Therapeutics, Inc. (expansion of Cambrooke Foods) was founded in 2000 by Lynn and David Paolella, the parents of two children diagnosed with a rare disease called phenylketonuria (PKU). PKU is one of the few genetic diseases, which is managed almost entirely with nutritional intervention. The Paolellas’ goal in forming Cambrooke was simple - to develop improved nutritional therapeutic options for those with serious medical disorders. Today, Cambrooke produces medical formulas and foods for the management of a variety of medical conditions and we are continually innovating new nutritional options targeted at a wide array of diseases. Ajinomoto Cambrooke, Inc. - Leaders in Therapeutic Medical Nutrition. Cambrooke was the first medical foods company to launch a natural intact protein for the dietary management of phenylketonuria called Glytactin™ (modified glycomacropeptide). Cambrooke collaborates with academia and industry partners to transform early phase development projects in therapeutic nutrition into viable commercial products. Cambrooke employs scientific experts in the development, manufacturing and commercialization of nutritional therapeutics for patients with rare diseases. Cambrooke’s products are supported by clinical evidence for the nutritional management of medical needs before they are selected for commercialization. Cambrooke believes that both large and small patient populations are important when it comes to complex nutritional requirements.
Employees by Management Level
Total employees: 51-100
Seniority
Employees
Employees by Department
Ajinomoto Cambrooke has 39 employees across 10 departments.
Departments
Number of employees
Ajinomoto Cambrooke Tech Stack
Discover the technologies and tools that power Ajinomoto Cambrooke's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
Widgets
JavaScript libraries
Maps
JavaScript libraries
Web servers
JavaScript libraries
Hosting
Analytics
UI frameworks
CRM
India
Canada
CroatiaFrequently asked questions
4.8
40,000 users
